{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:52:38Z","timestamp":1791406358744,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05797-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:01:21Z","timestamp":1789066881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the personal financial impact of vestibular schwannoma management"],"prefix":"10.1007","volume":"179","author":[{"given":"Robert J.","family":"Macielak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward E.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Prevedello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver F.","family":"Adunka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desi P.","family":"Schoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"5797_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.otc.2015.02.003","volume":"48","author":"ML Carlson","year":"2015","unstructured":"Carlson ML, Link MJ, Wanna GB, Driscoll CLW (2015) Management of sporadic vestibular schwannoma. Otolaryngol Clin North Am 48:407\u2013422. https:\/\/doi.org\/10.1016\/j.otc.2015.02.003","journal-title":"Otolaryngol Clin North Am"},{"key":"5797_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra2020394","volume":"384","author":"ML Carlson","year":"2021","unstructured":"Carlson ML, Link MJ (2021) Vestibular Schwannomas. N Engl J Med 384:1335\u20131348. https:\/\/doi.org\/10.1056\/NEJMra2020394","journal-title":"N Engl J Med"},{"key":"5797_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.otc.2023.02.016","volume":"56","author":"JP Marinelli","year":"2023","unstructured":"Marinelli JP, Lohse CM, Link MJ, Carlson ML (2023) Quality of Life in Sporadic Vestibular Schwannoma. Otolaryngol Clin North Am 56:577\u2013586. https:\/\/doi.org\/10.1016\/j.otc.2023.02.016","journal-title":"Otolaryngol Clin North Am"},{"key":"5797_CR4","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1097\/MAO.0000000000002445","volume":"41","author":"LE Miller","year":"2020","unstructured":"Miller LE, Brant JA, Naples JG et al (2020) Quality of Life in Vestibular Schwannoma Patients: A Longitudinal Study. Otol Neurotol 41:e256\u2013e261. https:\/\/doi.org\/10.1097\/MAO.0000000000002445","journal-title":"Otol Neurotol"},{"key":"5797_CR5","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/lary.25110","volume":"125","author":"ML Carlson","year":"2015","unstructured":"Carlson ML, Tveiten \u00d8V, Driscoll CL et al (2015) What drives quality of life in patients with sporadic vestibular schwannoma? Laryngoscope 125:1697\u20131702. https:\/\/doi.org\/10.1002\/lary.25110","journal-title":"Laryngoscope"},{"key":"5797_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/0194599817695800","volume":"157","author":"G Soulier","year":"2017","unstructured":"Soulier G, van Leeuwen BM, Putter H et al (2017) Quality of Life in 807 Patients with Vestibular Schwannoma: Comparing Treatment Modalities. Otolaryngology\u2013Head Neck Surg 157:92\u201398. https:\/\/doi.org\/10.1177\/0194599817695800","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"5797_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/0194599814524531","volume":"150","author":"ZN Robinett","year":"2014","unstructured":"Robinett ZN, Walz PC, Miles-Markley B et al (2014) Comparison of Long\u2010term Quality\u2010of\u2010Life Outcomes in Vestibular Schwannoma Patients. Otolaryngology\u2013Head Neck Surg 150:1024\u20131032. https:\/\/doi.org\/10.1177\/0194599814524531","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"5797_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3171\/2022.7.JNS221104","volume":"138","author":"ML Carlson","year":"2023","unstructured":"Carlson ML, Lohse CM, Link MJ et al (2023) Development and validation of a new disease-specific quality of life instrument for sporadic vestibular schwannoma: the Mayo Clinic Vestibular Schwannoma Quality of Life Index. J Neurosurg 138:981\u2013991. https:\/\/doi.org\/10.3171\/2022.7.JNS221104","journal-title":"J Neurosurg"},{"key":"5797_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3171\/2014.11.JNS14594","volume":"122","author":"ML Carlson","year":"2015","unstructured":"Carlson ML, Tveiten OV, Driscoll CL et al (2015) Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg 122:833\u2013842. https:\/\/doi.org\/10.3171\/2014.11.JNS14594","journal-title":"J Neurosurg"},{"key":"5797_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/01945998221088565","volume":"168","author":"OM Neve","year":"2023","unstructured":"Neve OM, Jansen JC, Koot RW et al (2023) Long-Term Quality of Life of Vestibular Schwannoma Patients: A Longitudinal Analysis. Otolaryngology\u2013Head Neck Surg 168:210\u2013217. https:\/\/doi.org\/10.1177\/01945998221088565","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"5797_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/0194599820941012","volume":"164","author":"CM Chweya","year":"2021","unstructured":"Chweya CM, Tombers NM, Lohse CM et al (2021) Disease-Specific Quality of Life in Vestibular Schwannoma: A National Cross\u2010sectional Study Comparing Microsurgery, Radiosurgery, and Observation. Otolaryngology\u2013Head Neck Surg 164:639\u2013644. https:\/\/doi.org\/10.1177\/0194599820941012","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"5797_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MAO.0000000000004495","volume":"46","author":"KR Khandalavala","year":"2025","unstructured":"Khandalavala KR, Lohse CM, Tombers NM et al (2025) Prospective Symptom Changes in Sporadic Vestibular Schwannoma: A Comparison of Observation, Microsurgery, and Radiosurgery. Otol Neurotol 46:581\u2013586. https:\/\/doi.org\/10.1097\/MAO.0000000000004495","journal-title":"Otol Neurotol"},{"key":"5797_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/0194599820986564","volume":"165","author":"JH Barnes","year":"2021","unstructured":"Barnes JH, Patel NS, Lohse CM et al (2021) Impact of Treatment on Vestibular Schwannoma\u2013Associated Symptoms: A Prospective Study Comparing Treatment Modalities. Otolaryngology\u2013Head Neck Surg 165:458\u2013464. https:\/\/doi.org\/10.1177\/0194599820986564","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"5797_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/coa.13691","volume":"46","author":"IMJ Pruijn","year":"2021","unstructured":"Pruijn IMJ, Kievit W, Hentschel MA et al (2021) What determines quality of life in patients with vestibular schwannoma? Clin Otolaryngol 46:412\u2013420. https:\/\/doi.org\/10.1111\/coa.13691","journal-title":"Clin Otolaryngol"},{"key":"5797_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11060-025-05386-2","volume":"176","author":"KR Khandalavala","year":"2026","unstructured":"Khandalavala KR, Zalaquett NG, Lohse CM et al (2026) Systematic review of disease-specific quality of life in patients with sporadic vestibular schwannoma. J Neurooncol 176:136. https:\/\/doi.org\/10.1007\/s11060-025-05386-2","journal-title":"J Neurooncol"},{"key":"5797_CR16","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1097\/MAO.0000000000002462","volume":"41","author":"CS Brown","year":"2020","unstructured":"Brown CS, Cooper MW, Peskoe SB et al (2020) Associations of Vestibular Tests With Penn Acoustic Neuroma Quality of Life Scores After Resection of Vestibular Schwannoma. Otology Neurotology 41:e241\u2013e249. https:\/\/doi.org\/10.1097\/MAO.0000000000002462","journal-title":"Otology Neurotology"},{"key":"5797_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MAO.0000000000003773","volume":"44","author":"C Fuentealba-Bassaletti","year":"2023","unstructured":"Fuentealba-Bassaletti C, Neve OM, van Esch BF et al (2023) Vestibular Complaints Impact on the Long-Term Quality of Life of Vestibular Schwannoma Patients. Otology Neurotology 44:161\u2013167. https:\/\/doi.org\/10.1097\/MAO.0000000000003773","journal-title":"Otology Neurotology"},{"key":"5797_CR18","first-page":"436","volume":"18","author":"JH Chung","year":"1997","unstructured":"Chung JH, Rigby PL, Jackler RK et al (1997) Socioeconomic impact of acoustic neuroma surgery. Am J Otol 18:436\u2013443","journal-title":"Am J Otol"},{"key":"5797_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1258\/002221503322683830","volume":"117","author":"T Tos","year":"2003","unstructured":"Tos T, Caye-Thomasen P, Stangerup S-E et al (2003) Long-term socio-economic impact of vestibular schwannoma for patients under observation and after surgery. J Laryngol Otol 117:955\u2013964. https:\/\/doi.org\/10.1258\/002221503322683830","journal-title":"J Laryngol Otol"},{"key":"5797_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/jnnp-2013-305168","volume":"85","author":"AR AL-Shudifat","year":"2014","unstructured":"AL-Shudifat AR, Kahlon B, Hoglund P et al (2014) Age, gender and tumour size predict work capacity after surgical treatment of vestibular schwannomas. J Neurol Neurosurg Psychiatry 85:106\u2013111. https:\/\/doi.org\/10.1136\/jnnp-2013-305168","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5797_CR21","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00405-021-06977-1","volume":"279","author":"OM Neve","year":"2022","unstructured":"Neve OM, Jansen JC, van der Mey AGL et al (2022) The impact of vestibular schwannoma and its management on employment. Eur Arch Otorhinolaryngol 279:2819\u20132826. https:\/\/doi.org\/10.1007\/s00405-021-06977-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5797_CR22","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.wneu.2013.03.069","volume":"80","author":"CN Breivik","year":"2013","unstructured":"Breivik CN, Nilsen RM, Myrseth E et al (2013) Working disability in Norwegian patients with vestibular schwannoma: vertigo predicts future dependence. World Neurosurg 80:e301\u2013e305. https:\/\/doi.org\/10.1016\/j.wneu.2013.03.069","journal-title":"World Neurosurg"},{"key":"5797_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10143-024-02305-3","volume":"47","author":"SW Koester","year":"2024","unstructured":"Koester SW, Bishay AE, Rogers JL et al (2024) Cost considerations for vestibular schwannoma screening and imaging: a systematic review. Neurosurg Rev 47:59. https:\/\/doi.org\/10.1007\/s10143-024-02305-3","journal-title":"Neurosurg Rev"},{"key":"5797_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/coa.12205","volume":"39","author":"C Gait","year":"2014","unstructured":"Gait C, Frew EJ, Martin TPC et al (2014) Conservative management, surgery and radiosurgery for treatment of vestibular schwannomas: a model-based approach to cost-effectiveness. Clin Otolaryngol 39:22\u201331. https:\/\/doi.org\/10.1111\/coa.12205","journal-title":"Clin Otolaryngol"},{"key":"5797_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/lary.20819","volume":"120","author":"D Morrison","year":"2010","unstructured":"Morrison D (2010) Management of patients with acoustic neuromas: a Markov decision analysis. Laryngoscope 120:783\u2013790. https:\/\/doi.org\/10.1002\/lary.20819","journal-title":"Laryngoscope"},{"key":"5797_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1749-4486.2009.02016.x","volume":"34","author":"S Verma","year":"2009","unstructured":"Verma S, Anthony R, Tsai V et al (2009) Evaluation of cost effectiveness for conservative and active management strategies for acoustic neuroma. Clin Otolaryngol 34:438\u2013446. https:\/\/doi.org\/10.1111\/j.1749-4486.2009.02016.x","journal-title":"Clin Otolaryngol"},{"key":"5797_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1055\/a-2162-1134","volume":"85","author":"SW Koester","year":"2024","unstructured":"Koester SW, Dambrino Iv RJ, Bhamidipati A et al (2024) Cost of Vestibular Schwannoma Treatment: A Systematic Review and Meta-Analysis. J Neurol Surg B Skull Base 85:659\u2013665. https:\/\/doi.org\/10.1055\/a-2162-1134","journal-title":"J Neurol Surg B Skull Base"},{"key":"5797_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3171\/2018.4.JNS18365","volume":"131","author":"H Abou-Al-Shaar","year":"2019","unstructured":"Abou-Al-Shaar H, Azab MA, Karsy M et al (2019) Assessment of costs in open surgery and stereotactic radiosurgery for vestibular schwannomas. J Neurosurg 131:561\u2013568. https:\/\/doi.org\/10.3171\/2018.4.JNS18365","journal-title":"J Neurosurg"},{"key":"5797_CR29","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2014.8.FOCUS14435","volume":"37","author":"CC Zygourakis","year":"2014","unstructured":"Zygourakis CC, Oh T, Sun MZ et al (2014) Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus 37:E8. https:\/\/doi.org\/10.3171\/2014.8.FOCUS14435","journal-title":"Neurosurg Focus"},{"key":"5797_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/coa.13326","volume":"44","author":"M Scholte","year":"2019","unstructured":"Scholte M, Hentschel MA, Hannink G et al (2019) In search of the most cost-effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study. Clin Otolaryngol 44:525\u2013533. https:\/\/doi.org\/10.1111\/coa.13326","journal-title":"Clin Otolaryngol"},{"key":"5797_CR31","doi-asserted-by":"publisher","first-page":"e1369","DOI":"10.1097\/MAO.0000000000003266","volume":"42","author":"RJ Macielak","year":"2021","unstructured":"Macielak RJ, Thao V, Borah BJ et al (2021) Lifetime Cost and Quality-Adjusted Life-Years Across Management Options for Small- and Medium-Sized Sporadic Vestibular Schwannoma. Otol Neurotol 42:e1369\u2013e1375. https:\/\/doi.org\/10.1097\/MAO.0000000000003266","journal-title":"Otol Neurotol"},{"key":"5797_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/lary.26589","volume":"128","author":"DH Coelho","year":"2018","unstructured":"Coelho DH, Tang Y, Suddarth B, Mamdani M (2018) MRI surveillance of vestibular schwannomas without contrast enhancement: Clinical and economic evaluation. Laryngoscope 128:202\u2013209. https:\/\/doi.org\/10.1002\/lary.26589","journal-title":"Laryngoscope"},{"key":"5797_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00234-017-1859-2","volume":"59","author":"MG Crowson","year":"2017","unstructured":"Crowson MG, Rocke DJ, Hoang JK et al (2017) Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss. Neuroradiology 59:727\u2013736. https:\/\/doi.org\/10.1007\/s00234-017-1859-2","journal-title":"Neuroradiology"},{"key":"5797_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/coa.12973","volume":"43","author":"M Scholte","year":"2018","unstructured":"Scholte M, Hentschel MA, Kunst HP et al (2018) Potential savings in the diagnosis of vestibular schwannoma. Clin Otolaryngol 43:285\u2013290. https:\/\/doi.org\/10.1111\/coa.12973","journal-title":"Clin Otolaryngol"},{"key":"5797_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.oraloncology.2019.06.023","volume":"95","author":"LJ Mady","year":"2019","unstructured":"Mady LJ, Lyu L, Owoc MS et al (2019) Understanding financial toxicity in head and neck cancer survivors. Oral Oncol 95:187\u2013193. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.023","journal-title":"Oral Oncol"},{"key":"5797_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jamaoto.2025.1313","volume":"151","author":"LJ Mady","year":"2025","unstructured":"Mady LJ, Baddour K, Owoc MS et al (2025) Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 151:750\u2013760. https:\/\/doi.org\/10.1001\/jamaoto.2025.1313","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5797_CR37","doi-asserted-by":"publisher","first-page":"e2255388","DOI":"10.1001\/jamanetworkopen.2022.55388","volume":"6","author":"AN Ehsan","year":"2023","unstructured":"Ehsan AN, Wu CA, Minasian A et al (2023) Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis. JAMA Netw Open 6:e2255388. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55388","journal-title":"JAMA Netw Open"},{"key":"5797_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ohn.1241","volume":"173","author":"M Armache","year":"2025","unstructured":"Armache M, Stemme R, Najjar W et al (2025) Financial Toxicity Across the Thyroid Cancer Care Continuum: A Systematic Review. Otolaryngol Head Neck Surg 173:1\u201316. https:\/\/doi.org\/10.1002\/ohn.1241","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5797_CR39","doi-asserted-by":"publisher","first-page":"e2025810","DOI":"10.1001\/jamanetworkopen.2020.25810","volume":"3","author":"A Arastu","year":"2020","unstructured":"Arastu A, Patel A, Mohile SG et al (2020) Assessment of Financial Toxicity Among Older Adults With Advanced Cancer. JAMA Netw Open 3:e2025810. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.25810","journal-title":"JAMA Netw Open"},{"key":"5797_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.euo.2021.02.007","volume":"4","author":"SK Bhanvadia","year":"2021","unstructured":"Bhanvadia SK, Psutka SP, Burg ML et al (2021) Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action. Eur Urol Oncol 4:396\u2013404. https:\/\/doi.org\/10.1016\/j.euo.2021.02.007","journal-title":"Eur Urol Oncol"},{"key":"5797_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/07347332.2022.2142877","volume":"41","author":"H Jiang","year":"2023","unstructured":"Jiang H, Lyu J, Mou W et al (2023) Prevalence and risk factors of self-reported financial toxicity in cancer survivors: A systematic review and meta-analyses. J Psychosoc Oncol 41:457\u2013474. https:\/\/doi.org\/10.1080\/07347332.2022.2142877","journal-title":"J Psychosoc Oncol"},{"key":"5797_CR42","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/j.prro.2019.10.005","volume":"10","author":"KA D\u2019Rummo","year":"2020","unstructured":"D\u2019Rummo KA, Miller L, TenNapel MJ, Shen X (2020) Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome. Pract Radiat Oncol 10:e322\u2013e329. https:\/\/doi.org\/10.1016\/j.prro.2019.10.005","journal-title":"Pract Radiat Oncol"},{"key":"5797_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MAO.0000000000002891","volume":"42","author":"SA Chan","year":"2021","unstructured":"Chan SA, Marinelli JP, Hahs-Vaughn DL et al (2021) Evolution in Management Trends of Sporadic Vestibular Schwannoma in the United States Over the Last Half-century. Otol Neurotol 42:300\u2013305. https:\/\/doi.org\/10.1097\/MAO.0000000000002891","journal-title":"Otol Neurotol"},{"key":"5797_CR44","doi-asserted-by":"publisher","first-page":"102731","DOI":"10.1016\/j.amjoto.2020.102731","volume":"41","author":"JP Marinelli","year":"2020","unstructured":"Marinelli JP, Spear SA, Hahs-Vaughn DL et al (2020) Regional variation in vestibular schwannoma management and patient support group participation across the United States. Am J Otolaryngol 41:102731. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102731","journal-title":"Am J Otolaryngol"},{"key":"5797_CR45","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/lary.29315","volume":"131","author":"RJ Macielak","year":"2021","unstructured":"Macielak RJ, Marinelli JP, Spear SA et al (2021) Hearing Status and Aural Rehabilitative Profile of 878 Patients With Sporadic Vestibular Schwannoma. Laryngoscope 131:1378\u20131381. https:\/\/doi.org\/10.1002\/lary.29315","journal-title":"Laryngoscope"},{"key":"5797_CR46","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA de Souza","year":"2014","unstructured":"de Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer 120:3245\u20133253. https:\/\/doi.org\/10.1002\/cncr.28814","journal-title":"Cancer"},{"key":"5797_CR47","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123:476\u2013484. https:\/\/doi.org\/10.1002\/cncr.30369","journal-title":"Cancer"},{"key":"5797_CR48","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1200\/jco.2015.33.15_suppl.6618","volume":"33","author":"JA De Souza","year":"2015","unstructured":"De Souza JA, Wroblewski K, Yap BJ et al (2015) Grading financial toxicity based upon its impact on health-related quality of life (HRQol). J Clin Oncol 33:6618\u20136618. https:\/\/doi.org\/10.1200\/jco.2015.33.15_suppl.6618","journal-title":"J Clin Oncol"},{"key":"5797_CR49","unstructured":"Sereika S, Engberg S (2006) Development of standardized sociodemographic and co-morbidity questionnaires. In: Sigma theta tau international honor society of nursing 17th international nursing research congress"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05797-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:03:37Z","timestamp":1791403417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05797-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5797"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05797-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was deemed exempt by The Ohio State University IRB (Protocol #2024E1376) and was performed in accordance with the Declaration of Helsinki and Belmont Report.","order":1,"name":"Ethics","label":"Human ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All included participants provided electronic consent prior to study participation. No identifiable information was collected from these participants.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed without commercial sponsorship or support.","order":3,"name":"Ethics","label":"Financial material & support","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This material has not been previously published in part or whole and is not currently under consideration for publication elsewhere.","order":4,"name":"Ethics","label":"Statement of originality","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OFA - Ownership interest in Advanced Cochlear Diagnostics, royalties from Advanced Bionics Inc., advisory board membership with Advanced Bionics Inc. and MED-EL Corporation, and research funding from Cochlear Americas; DMP - Consulting for Stryker, Integra, Leica Microsystems, and BK Medical, receiving royalties from KLS Martin, ACE Medical, and Mizuho.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}